Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  OTC Bulletin Board - Other OTC  >  Epirus Biopharmaceuticals Inc    EPRSQ

 SummaryQuotesChartsNewsCalendarCompanyFinancials 
Quotes 5-day view   Delayed Quote. Delayed Otc Bulletin Board - Othe…
12/05/2017 12/06/2017 12/07/2017 12/08/2017 12/11/2017 Date
0.0025(c) 0.0025(c) 0.007(c) 0.007(c) 0.005(c) Last
34 137 6 199 1 092 610 68 354 4 415 Volume
-44.44% 0.00% +180.00% 0.00% -28.57% Change
More quotes
Company
EPIRUS Biopharmaceuticals, Inc. is a biopharmaceutical company focused on building a pure-play, sustainable and profitable biosimilar business.It focuses on biosimilars, which are biologic drugs that are demonstrated to be highly similar to a previously approved biologic drug, known as a reference... 
More about the company
Latest news on EPIRUS BIOPHARMACEUTICALS
2016 EPIRUS Announces Reprioritization of Pipeline to Solely Focus on Biosimilars ..
2016 EPIRUS Biopharmaceuticals Reports Fourth Quarter and Fiscal Year 2015 Financi..
2016 EPIRUS Biopharmaceuticals to Release Fourth Quarter and Fiscal Year 2015 Fina..
2016 EPIRUS Biopharmaceuticals Initiates Pivotal Global Phase 3 Clinical Study for..
2016 EPIRUS Biopharmaceuticals to Participate in Bloomberg Intelligence Healthcare..
2016DJJ&J, AbbVie Shares Drop on Potential Drug Competition
2016 EPIRUS Biopharmaceuticals to Present at LEERINK Partners 5th Annual Global He..
2015 EPIRUS Biopharmaceuticals Provides Clinical Program Update on BOW015 (Inflixi..
2015 EPIRUS Biopharmaceuticals Reports Third Quarter 2015 Financial Results & Prov..
2015 EPIRUS Biopharmaceuticals Reschedules Its Third Quarter 2015 Financial Result..
More news
Sector news : Biotechnology & Medical Research - NEC
10:43a M&A dominates Europe share trading as oil leads gains
12/09 Tax-loss selling to pressure 2017's losers in December
11/30 GENMAB : and J&J 'love' partnership as some ponder takeover
11/27 MERCK AND : As Brexit looms, UK pitches new industry plan, wins support from Mer..
11/27 MERCK AND : As Brexit looms, UK pitches new industry plan, wins support from Mer..
More sector news : Biotechnology & Medical Research - NEC
Chart EPIRUS BIOPHARMACEUTICALS
Duration : Period :
Epirus Biopharmaceuticals  Technical Analysis Chart | EPRSQ | US29428P1075 | 4-Traders
Income Statement Evolution
Sector and Competitors
1st jan.Capitalization (M$)
EPIRUS BIOPHARMACEUTICALS INC-78.95%0
CELLTRION, INC.--.--%23 085
IQVIA HOLDINGS INC32.70%21 148
INCYTE CORPORATION-5.43%20 523
LONZA GROUP57.44%19 299
ALNYLAM PHARMACEUTICALS, INC.243.83%12 606